Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03099434 · ClinicalTrials.gov registry record · NA

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

A NA study of Kidney Diseases and Kidney Failure, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
775
Enrollment target
2
Study locations

NCT03099434 is a NA study of Kidney Diseases and Kidney Failure that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 775 participants, below the 1,765-participant average among 38 other Kidney Diseases trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03099434, a NA study of Kidney Diseases and Kidney Failure, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
775 participants
Enrollment target
2
Study locations

Study Summary

This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.

Interventions

  • BEHAVIORAL Facebook App
  • BEHAVIORAL Live Donor Champion + Facebook App

Study Locations (2)

Illinois

  • Northwestern University - Evanston

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 775 participants
Start Date 2017-04-01
Est. Completion 2026-12-07
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03099434

The ClinicalTrials.gov registry entry for NCT03099434 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 775 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,765-participant average among 38 other Kidney Diseases trials with a reported enrollment target (56% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Facebook App is the first listed.

NCT03099434 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Maryland.

Frequently Asked Questions

What is clinical trial NCT03099434 about?

NCT03099434 is a clinical study titled "Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media". This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.

What is the current status of trial NCT03099434?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 775 participants. The study started on 2017-04-01. Estimated completion is 2026-12-07.

What conditions does trial NCT03099434 study?

This clinical trial studies the following conditions: Kidney Diseases, Kidney Failure.

What interventions are being tested in trial NCT03099434?

The interventions under investigation include: Facebook App (BEHAVIORAL), Live Donor Champion + Facebook App (BEHAVIORAL).

Who is sponsoring clinical trial NCT03099434?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03099434 being conducted?

This trial has 2 study locations across Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.